
Matthew Giegengack MD
Cataract Related, Cornea & External Disease
Assistant Professor, Surgical Sciences, Bowman Gray School of Medicine of Wake Forest Univ
Join to View Full Profile
S Hawthorne RdWinston Salem, NC 27157
Phone+1 336-716-2255
Fax+1 336-716-7994
Dr. Giegengack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Ophthalmology, 2003 - 2006
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 2002 - 2003
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2002
Certifications & Licensure
- OR State Medical License 2006 - Present
- NC State Medical License 2007 - 2026
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only Start of enrollment: 2020 Nov 21
Publications & Presentations
PubMed
- Escalón: A Prospective Randomized Trial of Corneal Endothelial Cell Therapy in Subjects With Corneal Edema.Edward J Holland, Elizabeth Yeu, Matthew Giegengack, John Berdahl, Eris Jordan
Cornea. 2025-03-03 - A Comparison of Black and Non-Black Patients in the Presentation and Treatment of Keratoconus.Michael Christensen, Jeffrey Kartchner, Matthew Giegengack, Atalie C Thompson
Clinical Ophthalmology. 2024-01-01 - 29 citationsBioengineered multilayered human corneas from discarded human corneal tissue.Zhihua Zhang, Guoguang Niu, Jin San Choi, Matthew Giegengack, Anthony Atala
Biomedical Materials. 2015-06-24
Authored Content
- Innovative Cell Therapies in OphthalmologyNovember 2023
Press Mentions
- Innovative Cell Therapies in OphthalmologyNovember 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: